Second WHO high-level meeting on Ebola vaccines access and financing 8 January 2015 SUMMARY REPORT

125. The delegation of Saint Lucia agreed with Albania that an unlimited Urgent Safeguarding List was unrealistic as long as the resources and capacity of the

Taking stock of the progress made in implementing the global response to MDR-TB and XDR-TB, the task force noted that many positive developments had taken place since its

Significant potency drop For trivalent polio vaccine, > 0.6 log 10 when the mean potency of the heated vial is subtracted from the mean potency of control unheated vials....

The workshop contributed to address requests formulated by the WHO Executive Board during their special session on Ebola, 26 January 2015 and offered the Ebola Vaccines Deployment

The workshop contributed to address requests formulated by the WHO Executive Board during their special session on Ebola, 26 January 2015 and offered the Ebola Vaccines Deployment

Source: UNICEF/WHO survey database Source: WHO-UNICEF estimates: (The column under TT2plus actually refers to PAB, protection at birth) If no official estimate is available,

There is the possibility of using the LoaScope as part of a model-based mapping strategy that would identify communities in areas that are hypoendemic for onchocerciasis that need

In anticipation of the licensure of HPV vaccines within the next 2–3 years, the World Health Organization convened this consultation on 14–15 April 2005, to review available data